NasdaqGS - Nasdaq Real Time Price USD

Halozyme Therapeutics, Inc. (HALO)

50.23
-16.35
(-24.56%)
At close: May 13 at 4:00:02 PM EDT
50.30
+0.07
+(0.14%)
After hours: May 13 at 7:59:29 PM EDT

Insider Roster

Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.

Individual or EntityMost Recent TransactionDateShares Owned as of Transaction Date
CONNAUGHTON BERNADETTE M. Director Stock Award(Grant) May 1, 2025 50,952
DUNCAN BARBARA GAYLE Director Stock Award(Grant) May 1, 2025 19,919
HENDERSON JEFFREY WILLIAM Director Stock Award(Grant) May 1, 2025 32,776
KRISHNAN MAHESH M.D., MPH Director Stock Award(Grant) May 1, 2025 10,666
LABARRE MICHAEL J. Chief Technology Officer Sale Feb 27, 2025 173,756
LABROSSE NICOLE Chief Financial Officer Conversion of Exercise of derivative security Feb 21, 2025 31,900
MIYASHITA AKIKO MONI Director Stock Award(Grant) May 1, 2025 24,937
POSARD MATTHEW L Director Stock Award(Grant) May 1, 2025 74,039
SNYDER MARK HOWARD Officer Conversion of Exercise of derivative security Feb 21, 2025 28,489
TORLEY HELEN I Chief Executive Officer Conversion of Exercise of derivative security Feb 21, 2025 733,719

Related Tickers